|
| Issue Date | Title | Author(s) |
| 14-Dec-2018 | Alkylamine ion-pairing reagents and the chromatographic separation of oligonucleotides | Li, Ning; Morsy EL Zahar, Noha ; Saad, Jack G.; van der Hage, Erik R.E.; Bartlett, Michael G. |
| 1-Jul-2021 | Assessment of brain-to-blood drug distribution using liquid chromatography | Morsy EL Zahar, Noha ; Sutton, J. Michael; Bartlett, Michael G. |
| 1-Jul-2021 | BIOANALYSIS AND BIOTRANSFORMATION OF OLIGONUCLEOTIDE THERAPEUTICS BY LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY | Sutton, James Michael; Kim, Jaeah; Morsy EL Zahar, Noha ; Bartlett, Michael G. |
| 1-Jan-2018 | Chromatographic approaches for the characterization and quality control of therapeutic oligonucleotide impurities | Morsy EL Zahar, Noha ; Magdy, N.; El-Kosasy, A. M.; Bartlett, Michael G. |
| 1-Nov-1998 | Determination of degradation products from the calcium-channel blocker isradipine | Bartlett, Michael G.; Christopher Spell, J.; Mathis, Pheobe S.; Farouk Abdel Ghany, Maha ; El Zeany, Badr E.; Elkawy, Mohammed A.; Stewart, James T. |
| 1-Jul-2020 | In vitro metabolism of 2′-ribose unmodified and modified phosphorothioate oligonucleotide therapeutics using liquid chromatography mass spectrometry | Kim, Jaeah; Morsy EL Zahar, Noha ; Bartlett, Michael G. |
| 3-Feb-2021 | Oligonucleotide Anion Adduct Formation Using Negative Ion Electrospray Ion-Mobility Mass Spectrometry | Sutton, J. Michael; Morsy EL Zahar, Noha ; Bartlett, Michael G. |
